Metmost GV 2mg/500mg/0.3mg Tablet
Marketer
Biomax Biotechnics Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Metmost GV 2mg/500mg/0.3mg Tablet
Diabetics utilizing the anti-diabetic formulation, Metmost GV (2mg/500mg/0.3mg), a combined-therapy tablet, should adhere to prescribed dosage and timing. This medication manages blood glucose in adult patients with type 2 diabetes mellitus. Optimal effectiveness requires consistent daily intake, ideally alongside meals, as directed by your physician. Dosage adjustments may occur based on individual responses and blood sugar monitoring. Discontinuing this medication without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. A comprehensive diabetes management plan including diet, exercise, and weight management, as recommended by your doctor, is crucial for successful treatment. Hypoglycemia (low blood sugar) is a common adverse effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential for prevention. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, edema (swelling), visual disturbances, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease necessitates physician consultation before initiating treatment. Pregnant or lactating individuals should seek medical advice. Regular blood glucose monitoring, along with periodic blood tests (complete blood count and liver function tests), are recommended for ongoing evaluation.
Uses of Metmost GV 2mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Metmost GV 2mg/500mg/0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metmost GV 2mg/500mg/0.3mg tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.
Common Side effects of Metmost GV 2mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Metmost GV 2mg/500mg/0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metmost GV 2mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Metmost GV 2mg/500mg/0.3mg Tablet works:
Each Metmost GV tablet (2mg/500mg/0.3mg) contains a triple-action blend of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Metmost GV 2mg/500mg/0.3mg Tablet ingestion is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Metmost GV 2mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Metmost GV 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Metmost GV 2mg/500mg/0.3mg tablets in individuals with kidney impairment carries a significant risk and is best avoided. Patients should seek medical counsel before use. The use of Metmost GV 2mg/500mg/0.3mg tablets is contraindicated in those with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Metmost GV 2mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiating treatment with a low dose of Metmost GV 2mg/500mg/0.3mg tablets is typical; however, its use is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Metmost GV 2mg/500mg/0.3mg Tablet :
Should you forget to take a Metmost GV 2mg/500mg/0.3mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metmost GV 2mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Treatment |
3,018 People bought this recently